Literature DB >> 16490843

Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis.

Soon Bahrami1, Janine C Malone, Kelli G Webb, Jeffrey P Callen.   

Abstract

OBJECTIVE: To determine whether tissue eosinophilia is a reliable indicator of a drug-induced etiology in biopsy samples demonstrating leukocytoclastic vasculitis.
DESIGN: Retrospective medical record review with concurrent histopathologic analysis.
SETTING: University-affiliated dermatology practice. PATIENTS: Sixty-three patients with cutaneous small-vessel vasculitis meeting specific inclusion criteria were divided into drug-induced (n = 16) and non-drug-induced (n = 47) groups. MAIN OUTCOME MEASURES: Corresponding histopathologic material was reviewed by a dermatopathologist masked to the etiologic associations. An eosinophil ratio was calculated for each patient, derived from the mean eosinophil score (averaging eosinophil counts from 10 high-power histologic fields), and expressed in relation to the intensity of inflammation in the histopathologic slides examined. Eosinophilia ratios were compared for both groups using the Mann-Whitney test.
RESULTS: A significant difference was found in mean eosinophil ratios in the drug-induced vs non-drug-induced groups (5.20 vs 1.05; P = .01). Vascular fibrin deposition was present in both groups and was not found to be significantly different (P = .78). Clinical evidence of systemic vasculitis was present in 2 patients (13%) in the drug-induced group vs 15 (32%) in the non-drug-induced group. Fourteen patients (88%) in the drug-induced group had a short-term disease course vs 27 (57%) in the non-drug-induced group.
CONCLUSIONS: Tissue eosinophilia is established as a reliable indicator of drug induction in cutaneous small vessel vasculitis. Drug-induced small-vessel vasculitis generally follows a short-term disease course without development of systemic involvement. This information may be useful for guiding management decisions, especially when the etiology is unclear.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16490843     DOI: 10.1001/archderm.142.2.155

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  11 in total

1.  Leukocytoclastic Vasculitis Secondary to Pyridostigmine (Mestinon): Report of a Possible First Case.

Authors:  Gunveen Singh; Tim Hodgson; David E Clarke
Journal:  Perm J       Date:  2016-11-18

2.  Leukocytoclastic vasculitis drug reaction to certolizumab pegol.

Authors:  Meghan Woody; Donald Warren; Laura Speck; Julie Jackson
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-04

Review 3.  Eosinophils in vasculitis: characteristics and roles in pathogenesis.

Authors:  Paneez Khoury; Peter C Grayson; Amy D Klion
Journal:  Nat Rev Rheumatol       Date:  2014-07-08       Impact factor: 20.543

4.  Sibutramine (reductil®)-induced cutaneous leukocytoclastic vasculitis: a case report.

Authors:  You Jin Ha; You Jin Han; You Won Choi; Ki Bum Myung; Hae Young Choi
Journal:  Ann Dermatol       Date:  2011-11-03       Impact factor: 1.444

5.  An aetiological & clinicopathological study on cutaneous vasculitis.

Authors:  Pooja Khetan; Gomathy Sethuraman; Binod K Khaitan; Vinod K Sharma; Rajeeva Gupta; Amit K Dinda; V Sreenivas; Manoj K Singh
Journal:  Indian J Med Res       Date:  2012       Impact factor: 2.375

6.  Letrozole-induced necrotising leukocytoclastic small vessel vasculitis: First report of a case in the UK.

Authors:  Pirunthan Pathmarajah; Karishma Shah; Kathy Taghipour; Su Ramachandra; Mangesh A Thorat; Ziaullah Chaudhry; Vivek Patkar; Francesca Peters; Thomas Connor; Emma Spurrell; Jeffrey S Tobias; Jayant S Vaidya
Journal:  Int J Surg Case Rep       Date:  2015-09-26

Review 7.  Histopathology of drug eruptions - general criteria, common patterns, and differential diagnosis.

Authors:  Wolfgang Weyers; Dieter Metze
Journal:  Dermatol Pract Concept       Date:  2011-01-31

Review 8.  [Vasculitides and eosinophilic pulmonary diseases].

Authors:  C Kroegel; M Foerster; S Quickert; H Slevogt; T Neumann
Journal:  Internist (Berl)       Date:  2018-09       Impact factor: 0.834

9.  [Vasculitides and eosinophilic pulmonary diseases].

Authors:  C Kroegel; M Foerster; S Quickert; H Slevogt; T Neumann
Journal:  Z Rheumatol       Date:  2018-12       Impact factor: 1.530

10.  Blistering eruptions with tissue eosinophilia in a child with IgA vasculitis.

Authors:  Toru Watanabe; Shinya Tsukano
Journal:  Clin Case Rep       Date:  2018-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.